To fully participate in this online program you must be registered and logged in. Read all the information presented below. When ready select the "View Program" tab above.
Claiming CME/CE Credits
To receive credits, participants must review the program materials in their entirety and complete the online post examination and evaluation. CME credits require a post examination score of 70% or higher. CE credits require a post examination score of 80% or higher
Dr. Laurie Fajardo will share her understanding of the benefits of synthetic 2D images with digital breast tomosynthesis (DBT) for diagnosing breast cancer along with considerations for implementing Synthetic 2D breast imaging protocols into your practice. Following the presentation questions from the audience were addressed in a moderated Q&A session.
CME Effective Date: November 30, 2020
CME Expiration Date: November 29, 2023
CE Effective Date: December 15, 2021
CE Expiration Date: December 1, 2023
Format: Self Instructional - Audio Visual with Slides
One (1) AMA/PRA Category 1 CME Credit™
One (1) ARRT Category A CE Credit.
One (1) AHRA CRA Credit
Estimated Completion Time: 1 hour
This program is supported through an unrestricted educational grant from FUJIFILM Healthcare Americas Corporation.
This program is intended for: Radiologists, Other MD's, Radiologic Technologists, Radiology Administrators and related Imaging Professionals.
There is no cost to participate in this program.
Upon completion of this CME activity the healthcare provider should be able to:
No special educational preparation is required for this CME/CE Activity!
Laurie L. Fajardo, MD, MBA, FACR, FSBI
Department of Radiology and Imaging Sciences
University of Utah School of Medicine
Salt Lake City, Utah
LDr. Fajardo is a Professor of Radiology at the University of Utah. Previously, she served in academic breast imaging faculty positions at the University of Arizona, the University of Virginia, Johns Hopkins Medical Institutions and the University of Iowa.
Dr. Fajardo was an innovator in the development of stereotactic core breast biopsy, digital mammography, digital breast tomosynthesis and breast biopsy markers. As a result of her commitment to evaluating new breast imaging technologies and therapies, she has received numerous NIH, DOD and industry grants to support her research endeavors. Throughout her career, she has served with national organizations including: the Agency for Healthcare Policy and Research, the NCI/NIH, the American College of Radiology, the American College of Radiology Oncology Imaging Network, the Academy for Radiology Research, NIH Consensus Development Panel: Breast Cancer Screening in Women Ages 40-49, and on the Scientific Advisory Integration Panel for the USA MRDC-Army Breast Cancer Research Program.
In addition, Dr. Fajardo has served on executive committees and in editorial positions for the JACR, Academic Radiology, Radiology and AJR. She has delivered over 200 invited lectures and scientific papers nationally and internationally, and is the author of over 190 scientific papers. She graduated from the University of Chicago Pritzker School of Medicine and completed her radiology residency training and fellowship at the University of Arizona.
Dr. Fajardo has a particular interest in providing breast cancer screening to underserved and vulnerable populations.
IAME requires everyone who is in a position to control the content of a CE/CME activity to disclose all relevant financial relationships with any commercial interest. This information is utilized to 1) determine if a conflict exists, 2) resolve the conflict by initiating a content validation process, and 3) advise learners of this information. Any individual who refuses to (or chooses not to) disclose relevant financial relationships will be disqualified from participating as an instructor, planner or manager and cannot have control of or responsibility for the development, management, presentation or evaluation of a CE/CME activity certified by IAME.
Laurie L. Fajardo, MD, MBA, FACR, FSBI, Discloses she has served as a consultant to FUJIFILM Medical Systems U.S.A., Inc. and Hologic in the past 2 years.
No individual at IAME who had control over the content of this program has relationships with FUJIFILM Medical Systems U.S.A., Inc. or any other commercial interest.
The Institute for Advanced Medical Education (IAME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Institute for Advanced Medical Education (IAME) designates this enduring material for a maximum of 1.0 AMA/PRA Category 1 CME Credits.™ Physicians should only claim credit commensurate with the extent of their participation in the activity.
This course meets all criteria and has been approved by the AHRA, The Association for Medical Imaging Management for One (1) ARRT Category A CE Credit.
This course meets all CRA renewal credit criteria and has been approved for One (1) continuing education credit in the following CRA domains: Asset Resource Management (AM) and Operations Management (OM).
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board or other credentialing organization.
To receive CME credits for participating in this CME activity you must successfully complete the online post examination with a passing score of 70% or higher.
To receive CE credits for participating in this CE activity you must successfully complete the online post examination with a passing score of 80% or higher.
Online examinations return an immediate grade report. Upon receiving a passing score click Continue and complete the evaluation form. To view and print your Statement of Credit click the Print/View Certificate button displayed from within your MyAR Archives page.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.